Pharmaceutical Executive

Pharmaceutical Executive Podcast
  • ٤٫٩ (١٤)
  • علوم حياة
  • مرتان في الأسبوع

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

  1. Pharmaceutical Executive Daily: FDA Approves Breztri

    قبل ٢٢ ساعة

    Pharmaceutical Executive Daily: FDA Approves Breztri

    In today's Pharmaceutical Executive Daily, we cover Sun Pharma and IMG Pharma's respective acquisitions, FDA's approval of AstraZeneca's Breztri, and a new feature examining why Ireland has become one of the pharmaceutical industry's most strategically important global manufacturing hubs.

    ٣ د
  2. Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia

    قبل يوم واحد

    Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia

    In today's Pharmaceutical Executive Daily, Eli Lilly announces a definitive agreement to acquire Ajax Therapeutics for up to $2.3 billion, adding a first-in-class JAK2 inhibitor for blood cancers to its expanding oncology pipeline, the FDA approves a supplemental application for Johnson and Johnson's Caplyta backed by Phase III data showing a 63% reduction in relapse risk in adults with schizophrenia, and Pharmaceutical Executive speaks with Maher Masoud, CEO of MaxCyte, on moving cell and gene therapies toward commercial scale.

    ٣ د
  3. Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie

    قبل ٥ أيام

    Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie

    In today’s Pharmaceutical Executive Daily, the FDA issues a complete response letter to AbbVie for a biologics license application, Regeneron moves to lower patient costs tied to its newly approved gene therapy, and the FDA approves Otarmeni for OTOF-related hearing loss.

    **ASE.Web.Podcasts.Duration.Minute.two**
  4. Pharmaceutical Executive Daily: FDA Expands Approvals for Tzield and Dupixent

    قبل ٥ أيام

    Pharmaceutical Executive Daily: FDA Expands Approvals for Tzield and Dupixent

    In today’s Pharmaceutical Executive Daily, the FDA expands the use of Tzield to young children to delay the onset of stage 3 type 1 diabetes, Dupixent receives an expanded pediatric indication in chronic spontaneous urticaria, and AbbVie announces a $195 million investment to build a new manufacturing campus in North Carolina.

    **ASE.Web.Podcasts.Duration.Minute.two**
  5. The Ron Lanton Report: Where Innovations Happens

    قبل ٦ أيام

    The Ron Lanton Report: Where Innovations Happens

    In this episode, Ron Lanton examines how geography is becoming a central strategic variable in healthcare, as policy, trade dynamics, and infrastructure increasingly dictate where innovation is developed, manufactured, and commercialized.

    ٩ د
  6. Pharmaceutical Executive Daily: Idvynso Receives FDA Approval

    ٢٢ أبريل

    Pharmaceutical Executive Daily: Idvynso Receives FDA Approval

    In today’s Pharmaceutical Executive Daily, the FDA approves a new treatment for HIV-1 infection in adults, Amazon One Medical launches a GLP-1 weight management program, and a new report highlights which top-selling drugs are most at risk of supply shortages.

    **ASE.Web.Podcasts.Duration.Minute.two**
  7. Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast

    ٢١ أبريل

    Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast

    In today’s Pharmaceutical Executive Daily, UnitedHealth raises its full-year profit forecast following stronger-than-expected first-quarter results, Pfizer works to reshape its leadership narrative as it approaches a major patent cliff, and a new industry perspective highlights why scaling artificial intelligence in pharma requires more than just advanced algorithms.

    **ASE.Web.Podcasts.Duration.Minute.two**
  8. Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics

    ٢٠ أبريل

    Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics

    In today’s Pharmaceutical Executive Daily, Eli Lilly enters a $7 billion agreement to acquire Kelonia Therapeutics, the Trump administration issues an executive order to accelerate FDA reviews of psychedelic therapies, and Lilly’s oral weight loss pill sees strong early prescribing demand.

    **ASE.Web.Podcasts.Duration.Minute.two**
مشاهدة الكل (٣٤٣)

التقييمات والمراجعات

٤٫٩
من ٥
‫١٤ من التقييمات‬

حول

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

المعلومات

  • صناع العمل
    Pharmaceutical Executive Podcast
  • سنوات النشاط
    ٢٠١٨ - ٢٠٢٦
  • الحلقات
    ٣٤٣
  • التقييم
    ملائم
  • موقع البرنامج على الويب
    Pharmaceutical Executive

قد يعجبك أيضًا